Mingxia Yuan

532 total citations
28 papers, 356 citations indexed

About

Mingxia Yuan is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mingxia Yuan has authored 28 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mingxia Yuan's work include Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Diabetes Treatment and Management (7 papers) and Retinal Diseases and Treatments (5 papers). Mingxia Yuan is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Diabetes Treatment and Management (7 papers) and Retinal Diseases and Treatments (5 papers). Mingxia Yuan collaborates with scholars based in China, United States and Australia. Mingxia Yuan's co-authors include Jin‐Kui Yang, Xin Zhong, Xi Cao, Fangyuan Yang, Rong-Rong Xie, Jing Shi, Tingting Shi, Xuelian Zhang, Dong‐Ning Chen and Tingting Shi and has published in prestigious journals such as PLoS ONE, Diabetes and Scientific Reports.

In The Last Decade

Mingxia Yuan

26 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingxia Yuan China 11 113 76 76 75 72 28 356
Chloe Y. Y. Cheung Hong Kong 14 116 1.0× 72 0.9× 28 0.4× 84 1.1× 22 0.3× 29 456
Mariano J. Taverna Argentina 12 173 1.5× 61 0.8× 91 1.2× 129 1.7× 31 0.4× 19 511
Michele Mae Ann Yuen Hong Kong 13 123 1.1× 197 2.6× 27 0.4× 65 0.9× 63 0.9× 23 508
Anna E. Sieder Austria 8 57 0.5× 107 1.4× 33 0.4× 59 0.8× 20 0.3× 10 362
Marc Gregory Yu Philippines 9 138 1.2× 36 0.5× 19 0.3× 46 0.6× 24 0.3× 32 372
Stefanie Eising Denmark 12 274 2.4× 35 0.5× 74 1.0× 48 0.6× 61 0.8× 20 580
Jadwiga Peczyńska Poland 10 166 1.5× 108 1.4× 27 0.4× 60 0.8× 25 0.3× 42 424
Hui Lou China 9 79 0.7× 44 0.6× 46 0.6× 73 1.0× 16 0.2× 28 297
Domenico Merante United States 13 158 1.4× 39 0.5× 25 0.3× 59 0.8× 19 0.3× 28 520
Annamária Erdei Hungary 10 151 1.3× 33 0.4× 64 0.8× 34 0.5× 23 0.3× 32 353

Countries citing papers authored by Mingxia Yuan

Since Specialization
Citations

This map shows the geographic impact of Mingxia Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxia Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxia Yuan more than expected).

Fields of papers citing papers by Mingxia Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxia Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxia Yuan. The network helps show where Mingxia Yuan may publish in the future.

Co-authorship network of co-authors of Mingxia Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxia Yuan. A scholar is included among the top collaborators of Mingxia Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxia Yuan. Mingxia Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dong, Huijun, Mingxia Yuan, Jianrong Su, et al.. (2024). N-glycan as new potential biomarker for predicting treatment response in patients with type 2 diabetes mellitus. Biomarkers in Medicine. 18(24). 1113–1122. 1 indexed citations
3.
4.
Zhang, Weinan, Rong-Rong Xie, Gang Wan, et al.. (2022). Effect of Hemoglobin A1c Trajectories on Future Outcomes in a 10-Year Cohort With Type 2 Diabetes Mellitus. Frontiers in Endocrinology. 13. 846823–846823. 4 indexed citations
5.
6.
Pan, Qi, Mingxia Yuan, & Lixin Guo. (2022). Exposure–Response Analysis of Cardiovascular Outcome Trials With Incretin-Based Therapies. Frontiers in Endocrinology. 13. 893971–893971. 4 indexed citations
7.
8.
9.
Lü, Jing, et al.. (2020). Effect of KCNH6 on Hepatic Endoplasmic Reticulum Stress and Glucose Metabolism. Hormone and Metabolic Research. 52(9). 669–675. 2 indexed citations
10.
Lü, Jing, Cheng Cheng, Zhenchao Cheng, et al.. (2020). The dual role of RFX6 in directing β cell development and insulin production. Journal of Molecular Endocrinology. 66(2). 129–140. 7 indexed citations
11.
Shi, Tingting, Fangyuan Yang, Chang Liu, et al.. (2017). Angiotensin-converting enzyme 2 regulates mitochondrial function in pancreatic β-cells. Biochemical and Biophysical Research Communications. 495(1). 860–866. 43 indexed citations
12.
Cui, Jing, Dong‐Ning Chen, Xin Zhong, et al.. (2017). Prevalence and associated factors of diabetic retinopathy in Beijing, China: a cross-sectional study. BMJ Open. 7(8). e015473–e015473. 47 indexed citations
13.
Cao, Xi, Fangyuan Yang, Tingting Shi, et al.. (2016). Angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis. Scientific Reports. 6(1). 21592–21592. 68 indexed citations
14.
Gao, Lu, Xin Zhong, Mingxia Yuan, et al.. (2016). High Prevalence of Diabetic Retinopathy in Diabetic Patients Concomitant with Metabolic Syndrome. PLoS ONE. 11(1). e0145293–e0145293. 19 indexed citations
15.
Hsu, Fang‐Chi, Mingxia Yuan, Donald W. Bowden, et al.. (2016). Adiposity is inversely associated with hippocampal volume in African Americans and European Americans with diabetes. Journal of Diabetes and its Complications. 30(8). 1506–1512. 17 indexed citations
16.
Chen, Yi-Wen, Dong Zhao, Cai‐Guo Yu, et al.. (2015). High Prevalence of Lower Extremity Peripheral Artery Disease in Type 2 Diabetes Patients with Proliferative Diabetic Retinopathy. PLoS ONE. 10(3). e0122022–e0122022. 32 indexed citations
17.
18.
Zhong, Xin, Mingxia Yuan, Hongxing Li, et al.. (2012). Evaluation for Fasting and 2-hour Glucose and HbA1c for Diagnosing Diabetes Based on Prevalence of Retinopathy in a Chinese Population. PLoS ONE. 7(7). e40610–e40610. 27 indexed citations
19.
20.
Yao, Jun, Junjiang Liu, Mingxia Yuan, et al.. (2008). Multi-center,randomized,double-masked,double-mimic active-controlled clinical trial of glipizide/metformin hydrochloride tablets for patients with type 2 diabetes. The Chinese Journal of Clinical Pharmacology. 24(5). 387–391. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chloe Y. Y. Cheung Breakdown of academic impact, for papers by Mariano J. Taverna Breakdown of academic impact, for papers by Michele Mae Ann Yuen Breakdown of academic impact, for papers by Anna E. Sieder Breakdown of academic impact, for papers by Marc Gregory Yu Breakdown of academic impact, for papers by Stefanie Eising Breakdown of academic impact, for papers by Jadwiga Peczyńska Breakdown of academic impact, for papers by Hui Lou Breakdown of academic impact, for papers by Domenico Merante Breakdown of academic impact, for papers by Annamária Erdei
Rankless by CCL
2026